Outcomes for COPD pharmacological trials: from lung function to Biomarkers

M. Cazzola, W. MacNee, F.J. Martinez, et al.

Source: Guideline 2008
Number: 2008
Disease area: Airway diseases

PDF journal article, handout or slides

Rating: 5
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Cazzola, W. MacNee, F.J. Martinez, et al.. Outcomes for COPD pharmacological trials: from lung function to Biomarkers. Guideline 2008

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.

Related content which might interest you:
Outcomes for COPD pharmacological trials: from lung function to biomarkers
Source: Eur Respir J 2008; 31: 416-469
Year: 2008

Individual dynamic of inflammatory markers as indicators of COPD treatment effectiveness
Source: International Congress 2014 – COPD: points to ponder
Year: 2014

LATE-BREAKING ABSTRACT: Biomarkers of ECM turnover and clinical relevant outcomes in COPD: Results of the multicenter PROMISE study
Source: International Congress 2015 – Notable abstracts in COPD: variety
Year: 2015

Lung function decline in COPD trials
Source: Eur Respir J 2009; 33: 708-709
Year: 2009

Pharmacological treatment of COPD in the on-sint cohort
Source: International Congress 2014 – COPD exacerbations
Year: 2014

Functional Respiratory Imaging as a sensitive biomarker to assess therapeutic interventions in lung diseases
Source: International Congress 2015 – Functional and imaging techniques for assessing lung, airway and respiratory muscles
Year: 2015

Evaluating cardiac safety of tiotropium in patients with COPD: Combined analysis of Holter-ECG data from four trials
Source: International Congress 2014 – Clinical trials of drugs and biomarkers for respiratory diseases
Year: 2014

Lung function with aclidinium/formoterol fixed-dose combination: Pooled analysis of two phase III studies in COPD
Source: International Congress 2015 – Safety of and interactions between current treatments for asthma and COPD
Year: 2015

Roflumilast for stable COPD: Meta-analysis of randomized controlled trials
Source: International Congress 2014 – Clinical presentations
Year: 2014

Bronchodilator response of advanced lung function parameters depending on COPD severity
Source: International Congress 2016 – Functional assessment of the airways
Year: 2016

Laboratory and clinical parameters in predicting risk of future exacerbations in both non-smoking and smoking COPD patients
Source: International Congress 2014 – Systemic biomarkers for airway diseases
Year: 2014

Endpoints in IPF and lung cancer trials: controversies and perspectives
Source: Research Seminar 2015
Year: 2015

Lung cancer screening in COPD patients: NLST criteria vs a COPD screening score
Source: International Congress 2014 – The assessment of comorbidities
Year: 2014

Biomarkers in COPD exacerbation, the role of adiponectin
Source: International Congress 2014 – Predictors
Year: 2014

Body-plethysmographic measurements of bronchodilator response in stable COPD
Source: International Congress 2014 – Airways: reversibility and responsiveness
Year: 2014

Assessment of lung function in patients with COPD using the Inspired Sinewave Technique
Source: International Congress 2017 – Lung function testing in different patient categories
Year: 2017

Lung function and treatment patterns of symptomatic patients with moderate COPD in the CRYSTAL study
Source: International Congress 2016 – Novel avenues in the treatment of COPD I
Year: 2016

Pulmonary hypertension and COPD: Clinical assessment and biomarkers
Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension II
Year: 2013

The effects of bronchodilators on regional lung sound distribution in patients with COPD
Source: Annual Congress 2013 –Respiratory and cardiovascular abnormalities in COPD: the role of exercise, nutritional status and inflammation
Year: 2013

Relation of plasma osteopontin levels with the clinical course in patients with COPD
Source: International Congress 2014 – Systemic and airway biomarkers
Year: 2014